HomeFUSN • NASDAQ
add
Fusion Pharmaceuticals Inc
Previous close
$21.40
Day range
$21.37 - $21.48
Year range
$2.31 - $21.55
Market cap
1.82B USD
Avg Volume
3.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 7.63M | 9.76% |
Net income | -28.18M | -14.47% |
Net profit margin | — | — |
Earnings per share | -0.39 | 29.09% |
EBITDA | -27.91M | -15.50% |
Effective tax rate | -4.82% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 233.61M | 36.71% |
Total assets | 285.84M | 30.48% |
Total liabilities | 63.36M | 11.46% |
Total equity | 222.48M | — |
Shares outstanding | 84.69M | — |
Price to book | 7.67 | — |
Return on assets | -26.22% | — |
Return on capital | -27.51% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -28.18M | -14.47% |
Cash from operations | -17.94M | 7.33% |
Cash from investing | -5.24M | 87.79% |
Cash from financing | 57.86M | 44,064.12% |
Net change in cash | 34.67M | 155.77% |
Free cash flow | -13.50M | -34.58% |
About
Founded
2014
Headquarters
Website
Employees
113